Keyphrases
Alum Adjuvant
100%
Rheumatoid Arthritis
83%
Intramuscular Vaccine
75%
Vaccination
49%
Intramuscular Vaccination
33%
Recall Antigen
33%
HLA-DR Expression
33%
Prospective Randomized Trial
33%
Humoral Antibody Response
33%
Booster Injection
33%
Clinical Activity
33%
Potential Change
33%
Randomized Placebo-controlled Trial
33%
Peptide Vaccine
33%
Immunogenicity
25%
Phase II Study
24%
Immunology and Microbiology
Peptides
100%
Inflammatory Arthritis
87%
Humoral Antibody
37%
HLA-DR
37%
Peptide Vaccine
37%
Immunogenicity
25%
Pharmacology, Toxicology and Pharmaceutical Science
Rheumatoid Arthritis
100%
Peptide Vaccine
62%
Humoral Antibody
62%
Placebo
37%
Immunogenicity
25%
Placebo-Controlled Study
25%